Osteoporosis: prevention and treatment

被引：0
作者：
Tkaczuk-Wlach, Joanna [1 ]
Sobstyl, Malgorzata [1 ]
Jakiel, Grzegorz [2 ]
机构：
[1] Uniwersytet Med Lublinie, Katedra & Klin Ginekol & Endokrynol Ginekol, Lublin, Poland
[2] CMKP Warszawie, Klin Poloznictwa & Ginekol, Warsaw, Poland
来源：
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY | 2010年 / 9卷 / 04期
关键词：
osteoporosis; diagnosis of osteoporosis; prevention; treatment; FRACTURE RISK REDUCTION; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURE; STRONTIUM RANELATE; SALMON-CALCITONIN; MULTIPLE OUTCOMES; WEIGHT-LOSS; BONE LOSS; RALOXIFENE; RISEDRONATE;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The aim of the osteoporosis management is to reduce the risk of fracture. The primary clinical goal is to identify patients at high risk of fracture rather than to identify men or women with osteoporosis. This article summarizes current knowledge about effective prevention and treatment of osteoporosis.
引用
收藏
页码：283 / 287
页数：5
相关论文
共 32 条
  • [1] Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial
    Barrett-Connor, E
    Grady, D
    Sashegyi, A
    Anderson, PW
    Cox, DA
    Hoszowski, K
    Rautaharju, P
    Harper, KD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07): : 847 - 857
  • [2] Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model
    Bennink, H. J. T. Coelingh
    Heegaard, A. -M.
    Visser, M.
    Holinka, C. F.
    Christiansen, C.
    [J]. CLIMACTERIC, 2008, 11 : 2 - 14
  • [3] BINGHAMWRIGHT JC, 2007, RHEUMATOLOGY, V46, P257
  • [4] Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial
    Black, DM
    Thompson, DE
    Bauer, DC
    Ensrud, K
    Musliner, T
    Hochberg, MC
    Nevitt, MC
    Suryawanshi, S
    Cummings, SR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) : 4118 - 4124
  • [5] BLAU LA, 2000, J CLIN ENDOCR METAB, V85, P720
  • [6] Bonnick SL, 2010, MENOPAUSE, V17, P25, DOI [10.1097/gme.0b013e3181e617e6, 10.1097/gme.0b013e3181c617e6]
  • [7] A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
    Chesnut, CH
    Silverman, S
    Andriano, K
    Genant, H
    Gimona, A
    Harris, S
    Kiel, D
    LeBoff, M
    Maricic, M
    Miller, P
    Moniz, C
    Peacock, M
    Richardson, P
    Watts, N
    Baylink, D
    [J]. AMERICAN JOURNAL OF MEDICINE, 2000, 109 (04) : 267 - 276
  • [8] Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
    Delmas, PD
    Ensrud, KE
    Adachi, JD
    Harper, KD
    Sarkar, S
    Gennari, C
    Reginster, JY
    Pols, HAP
    Recker, RR
    Harris, ST
    Wu, WT
    Genant, HK
    Black, DM
    Eastell, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) : 3609 - 3617
  • [9] Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women
    Ensrud, KE
    Ewing, SK
    Stone, KL
    Cauley, JA
    Bowman, PJ
    Cummings, SR
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (12) : 1740 - 1747
  • [10] Ervin R Bethene, 2004, Adv Data, P1
1234